In preclinical studies, the same effects that make GLP-1 receptor agonists (RA) effective treatments for appetite suppression and weight loss, can often become obstaclescomplicating the evaluation of toxicological outcomes during preclinical development
El Camino Inca es muy popular, ya que te lleva a lo largo del verdadero sendero por el que recorran los incas
Sjstrm L, Rissanen A, Andersen T, et al
Murine pancreatic cancer cell lines were generated from pancreatic ductal adenocarcinoma tumors of Pdx1-Cre
Why it matters: GLP-1 market share swung from Novo to Lilly particularly in the US, but theres a new battle on the horizon that both hope to win in next generation oral medicines for weight loss
The companies that will define the GLP-1 era in food are not those making the quickest label changes